Mutation of R555 in CFTR-delta F508 enhances function and partially corrects defective processing
- PMID: 8723647
Mutation of R555 in CFTR-delta F508 enhances function and partially corrects defective processing
Abstract
The most common cystic fibrosis mutation deletes phenylalanine 508 in CFTR (CFTR-F508). This mutation causes the loss of CFTR Cl- channel activity by disrupting biosynthetic processing so that mutant protein does not reach the plasma membrane. It also decreases the rate at which mutant channels open. To identify second-site mutations that could reverse the effects of delta F508, we used a chimeric yeast STE6/CFTR system bearing the delta F508 mutation. This chimera manifests defective mating. After mutagenesis of the first nucleotide-binding domain, we found that mutation R555K partially restored mating. However, it also increased mating in the chimera lacking the delta F508 mutation. When we introduced the R555K mutation into human CFTR-delta F508, we found that the loss of apical Cl- current caused by delta F508 was partially restored, predominantly due to a partial correction of the delta F508 processing defect. Analysis of single CFTR Cl- channels showed that the R555K mutation did not correct the prolonged closed time associated with delta F508, rather it increased activity of both wild-type and delta F508 channels by prolonging the duration of bursts of activity. These data suggest that the region around residue R555 in the first nucleotide-binding domain is important both in determining the ability of the delta F508 protein to be properly processed and in determining channel function.
Similar articles
-
Analysis of the localization of STE6/CFTR chimeras in a Saccharomyces cerevisiae model for the cystic fibrosis defect CFTR delta F508.Mol Microbiol. 1996 Mar;19(5):1007-17. doi: 10.1046/j.1365-2958.1996.444973.x. Mol Microbiol. 1996. PMID: 8830258
-
Identification of revertants for the cystic fibrosis delta F508 mutation using STE6-CFTR chimeras in yeast.Cell. 1993 Apr 23;73(2):335-46. doi: 10.1016/0092-8674(93)90233-g. Cell. 1993. PMID: 7682896
-
A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.Mol Med. 2002 Feb;8(2):75-87. Mol Med. 2002. PMID: 12080183 Free PMC article.
-
Defects in processing and trafficking of cystic fibrosis transmembrane conductance regulator.Exp Nephrol. 2000 Nov-Dec;8(6):332-42. doi: 10.1159/000020687. Exp Nephrol. 2000. PMID: 11014930 Review.
-
Dysfunction of CFTR bearing the delta F508 mutation.J Cell Sci Suppl. 1993;17:235-9. J Cell Sci Suppl. 1993. PMID: 7511616 Review.
Cited by
-
Pharmacological chaperone-rescued cystic fibrosis CFTR-F508del mutant overcomes PRAF2-gated access to endoplasmic reticulum exit sites.Cell Mol Life Sci. 2022 Sep 27;79(10):530. doi: 10.1007/s00018-022-04554-1. Cell Mol Life Sci. 2022. PMID: 36167862
-
Synonymous codon usage affects the expression of wild type and F508del CFTR.J Mol Biol. 2015 Mar 27;427(6 Pt B):1464-1479. doi: 10.1016/j.jmb.2015.02.003. Epub 2015 Feb 10. J Mol Biol. 2015. PMID: 25676312 Free PMC article.
-
Biogenesis of the Saccharomyces cerevisiae pheromone a-factor, from yeast mating to human disease.Microbiol Mol Biol Rev. 2012 Sep;76(3):626-51. doi: 10.1128/MMBR.00010-12. Microbiol Mol Biol Rev. 2012. PMID: 22933563 Free PMC article. Review.
-
Biochemical and biophysical approaches to probe CFTR structure.Methods Mol Biol. 2011;741:365-76. doi: 10.1007/978-1-61779-117-8_24. Methods Mol Biol. 2011. PMID: 21594797 Free PMC article.
-
Building an understanding of cystic fibrosis on the foundation of ABC transporter structures.J Bioenerg Biomembr. 2007 Dec;39(5-6):499-505. doi: 10.1007/s10863-007-9117-7. J Bioenerg Biomembr. 2007. PMID: 18080175
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical